NEW YORK (Reuters) - Cardinal Health Inc.(CAH.N: Quote, Profile, Research, Stock Buzz) Chief Executive R. Kerry Clark said on Thursday he is evaluating whether to cut the company's ailing drug manufacturing business as part of his efforts to reshape the sprawling company.
Clark, speaking at the Reuters Health Summit in New York, said he also is working to heal bruised customer relations stemming from a sharp consolidation of its customer service calling centers.
The former Procter & Gamble Co.(PG.N: Quote, Profile, Research, Stock Buzz) executive said Cardinal will continue to seek "tuck in" acquisitions and also will consider divestitures over the next year. "We're not planning to make any major acquisitions soon," he said.
He also said he plans to cut deals with low-cost drug manufacturers and he sees the chance to undercut Wal-Mart Stores Inc., which recently announced a plan to offer certain generic drugs for $4.
© Thomson Reuters 2008. All rights reserved.
| Paper | Aug 20 - 21, 2008 | Manufacturing |
| Japan Investment | Jul 01 - 2, 2008 | Country Summits |
| Global Real Estate | Jun 23 - 25, 2008 | Real Estate |
| Consumer and Retail | Jun 16 - 18, 2008 | Consumer Retail |
| Investment Outlook | Jun 09 - 12, 2008 | Financial Services / Exchanges |
